The Australian Government is investing $100 million in funding into the development of new technologies to improve the diagnosis and treatment of stroke, epilepsy and lung disease, including COVID-19.
The Morrison Government is investing $100 million into the development of new technologies to improve diagnosis and treatment of stroke, epilepsy and lung disease, including COVID-19.
This funding from the Medical Research Future Fund’s Frontier Health and Medical Research initiative will support the development of:
The funding will be split across three research projects led by senior researchers at the University of Melbourne, the Australian Lung Health Initiative, and the Florey Institute of Neuroscience and Mental Health.
The five-year funding is being provided under Stage Two of the Frontier Health and Medical Research Initiative, an unprecedented program that allows researcher collaborations to explore the boldest and exciting ideas that could have a dramatic, global impact on health care.
The successful projects were chosen from 10 applicants, which each received up to $1.5 million in funding to develop ground-breaking ideas into research plans. The research plans were then assessed by an independent committee of Australian and international experts.
The selected projects are:
These projects have the potential to transform outcomes for people living with these diseases, generate massive economic benefits and create thousands of jobs.
All projects that have so far received funding through Frontiers have remarkable promise. Our Government is extremely impressed by the calibre of all the projects and their potential to assist people with many serious health issues, while also growing our innovation economy.
The Government has allocated a total of $570 million to the program, over ten years from 2019-20.
Join our mailing list to be on the front lines of healthcare , get exclusive content, and promos.